Summary Information:
Twist Bioscience Corporation Common Stock
NASDAQ:TWST


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Twist Bioscience Corporation Common Stock
Exchange: NASDAQ
Symbol: TWST
SEC CIK: 0001581280
Phone: 800-719-0671
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO CA 94080

CEO: Emily Leproust
Price when page updated: 24.63 Date: 2023-12-02
Company Website:
www.twistbioscience.com

_Description: Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by 'writing' DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

IPO YEAR:
2018
Sector:
Health Care
Industry:
Managed Health Care
ADRTSO:

MarketCap:
1420505226.00
Beta:
2.681927079027649
52 Week High:
214.07
52 Week Low:
73.18
52 Week Change:
-0.4974644712953108
Short Interest:

Short Date:

Shares Outstanding:
49632483
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
21 Nov 2022
Float:
0
return on Equity:
-28.80%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
-$219.22
ttmEPS:
0
Revenue:
$184.209M
Gross Profit:

Cash:

Debt:

Institution Percent:
-
Revenue Percent:

Revenue Per Employee:

Insider Percent:
1.00%
Return on Assets:
-23.80%
Return on Capital:

Profit Margin:
-
Price to Sales:
9.55
Price To Book:
2.01
Short Ratio:
6.06
PE Ratio:
0
Employees:
525
1Y Guesstimate
43.496:1.0:6




__The following are links to various summary and news pages for
__Twist Bioscience Corporation Common Stock [ TWST ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-02